RCUS vs XNCR: stock comparison and AI forecast
Arcus Biosciences, Inc. (RCUS) and Xencor Inc (XNCR) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
RCUS Arcus Biosciences, Inc.
- Price
- $19.31 -25.7% · 6M
- Market Cap
- $2.55B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
XNCR Xencor Inc
- Price
- $34.05 +161.7% · 6M
- Market Cap
- $2.53B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- RCUS and XNCR have similar market capitalizations ($2.55B and $2.53B).
- Over the last six months XNCR returned +161.7% and RCUS -25.7%.
- XNCR turns -81.4% of its revenue into net income, against -453.0% for RCUS.
- RCUS carries 1.28 times debt per unit of equity, against 0.37 times for XNCR.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | RCUS | XNCR |
|---|---|---|
| Market Cap | $2.55B | $2.53B |
| P/B Ratio | 7.12x | 4.52x |
| EPS | $-3.62 | $-2.24 |
| Book Value/Share | $2.48 | $7.53 |
| Revenue/Share | $0.69 | $1.95 |
| FCF/Share | $-3.23 | $-2.37 |
Profitability & Margins
| Metric | RCUS | XNCR |
|---|---|---|
| ROE | -126.5% | -21.0% |
| ROA | -55.4% | -15.3% |
| ROIC | -76.7% | -21.0% |
| Operating Margin | -475.0% | -100.7% |
| Net Margin | -453.0% | -81.4% |
| EBT Margin | -453.0% | -79.8% |
| Tax Rate | 0.0% | -2.0% |
Financial Health
| Metric | RCUS | XNCR |
|---|---|---|
| Current Ratio | 3.34x | 6.54x |
| D/E Ratio | 1.28x | 0.37x |
| Financial Leverage | 2.28x | 1.37x |
| Interest Coverage | -43.7x | -9267.0x |
| Working Capital | $465M | $422M |
Cash Flow
| Metric | RCUS | XNCR |
|---|---|---|
| Operating Cash Flow | -$465M | -$172M |
| Free Cash Flow | -$466M | -$176M |
| Capital Spending | -$1M | -$4M |
| FCF/Sales | -466.0% | -121.9% |
| CapEx/Sales | 1.0% | 2.8% |
Operational Efficiency
| Metric | RCUS | XNCR |
|---|---|---|
| Asset Turnover | 0.12x | 0.19x |
| Receivables Turnover | – | 2.2x |
| Fixed Assets Turnover | 3.0x | 2.9x |
| Days Sales Outstanding | – | 163 days |
Income Statement
| Metric | RCUS | XNCR |
|---|---|---|
| Total Revenue | $100M | $145M |
| Operating Income | -$475M | -$146M |
| Net Income | -$453M | -$118M |
| R&D Expense | $473M | $286M |
Dividend & Shareholder Information
| Metric | RCUS | XNCR |
|---|---|---|
| Shares Outstanding | 144M | 74M |
RCUS vs XNCR: stock comparison and AI forecast
Which is bigger, RCUS or XNCR?
RCUS and XNCR have similar market capitalizations ($2.55B and $2.53B).
Which stock performed better over the last six months, RCUS or XNCR?
Over the last six months XNCR returned +161.7% and RCUS -25.7%.
Which one does Intratio's AI model rank higher, RCUS or XNCR?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.